Literature DB >> 1088637

ad and ay subtypes of hepatitis B antigen in a case of hypogammaglobulinaemia.

J W Lawton, R Hopkins, I C Paterson, P C Das.   

Abstract

We describe the finding of d and y specificities of hepatitis B surface antigen (HBsAg) in a case of hypogammaglobulinaemia of the 'common variable' type treated with fresh frozen plasma infusions. Absorption studies show that the two specificities are on separate particles, suggesting dual infection. It raises important questions regarding the relationship between HBsAg persistence and the immune status of the carrier.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1088637      PMCID： PMC475884          DOI： 10.1136/jcp.28.11.863

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  20 in total

Review 1.  Persistent viral hepatitis.

Authors: 
Journal:  Am J Med       Date:  1973-12       Impact factor: 4.965

2.  Additional specificities of Australia antigen and the possible identification of hepatitis carriers.

Authors:  C Levene; B S Blumberg
Journal:  Nature       Date:  1969-01-11       Impact factor: 49.962

3.  Proceedings: Immunoprophylaxis of hepatitis B by human anti-HB-Ag immunoglobulin following accidental inoculation.

Authors:  P C Das; R Hopkins
Journal:  Br J Haematol       Date:  1974-09       Impact factor: 6.998

4.  Australia antigen (HB-Ag) subtyping by a sensitive tanned cell haemagglutination-inhibition technique.

Authors:  R Hopkins; P C Das
Journal:  Br J Haematol       Date:  1974-07       Impact factor: 6.998

5.  The heterogeneity of Australia antigen.

Authors:  G L Le Bouvier
Journal:  J Infect Dis       Date:  1971-06       Impact factor: 5.226

Review 6.  Australia antigen, posttransfusion hepatitis, and the chronic carrier state.

Authors:  A I Sutnick; W T London; B S Blumberg; A Vierucci
Journal:  Am J Dis Child       Date:  1972-04

7.  A tanned cell haemagglutination test for the detection of hepatitis-associated-antigen (Au-Ag) and antibody (anti-Au).

Authors:  R Hopkins; P C Das
Journal:  Br J Haematol       Date:  1973-11       Impact factor: 6.998

8.  Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis.

Authors:  A L Eddleston; R Williams
Journal:  Lancet       Date:  1974-12-28       Impact factor: 79.321

9.  Australia antigen and lepromatous leprosy studies in South India and elsewhere.

Authors:  B S Blumberg; L Melartin
Journal:  Int J Lepr Other Mycobact Dis       Date:  1970 Jan-Mar

10.  Cell-mediated immunity in patients positive for hepatitis-associated antigen.

Authors:  F J Dudley; V Giustino; S Sherlock
Journal:  Br Med J       Date:  1972-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.